1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians 2018, 68(6):394-424.
2. Salzman J: Circular RNA Expression: Its Potential Regulation and Function. Trends in genetics : TIG 2016, 32(5):309-316.
3. Xu Z, Li P, Fan L, Wu M: The Potential Role of circRNA in Tumor Immunity Regulation and Immunotherapy. Frontiers in immunology 2018, 9:9.
4. Zhang L: Circular RNA: The main regulator of energy metabolic reprogramming in cancer cells. Thoracic cancer 2020, 11(1):6-7.
5. Cao L, Wang M, Dong Y, Xu B, Chen J, Ding Y, Qiu S, Li L, Karamfilova Zaharieva E, Zhou X et al: Circular RNA circRNF20 promotes breast cancer tumorigenesis and Warburg effect through miR-487a/HIF-1alpha/HK2. Cell Death Dis 2020, 11(2):145.
6. Taborda MI, Ramirez S, Bernal G: Circular RNAs in colorectal cancer: Possible roles in regulation of cancer cells. World journal of gastrointestinal oncology 2017, 9(2):62-69.
7. Fischer JW, Leung AK: CircRNAs: a regulator of cellular stress. Critical reviews in biochemistry and molecular biology 2017, 52(2):220-233.
8. Liu B, Yang G, Wang X, Liu J, Lu Z, Wang Q, Xu B, Liu Z, Li J: CircBACH1 (hsa_circ_0061395) promotes hepatocellular carcinoma growth by regulating p27 repression via HuR. J Cell Physiol 2020.
9. Hu ZQ, Zhou SL, Li J, Zhou ZJ, Wang PC, Xin HY, Mao L, Luo CB, Yu SY, Huang XW et al: Circular RNA Sequencing Identifies CircASAP1 as a Key Regulator in Hepatocellular Carcinoma Metastasis. Hepatology 2019.
10. Teng KY, Han J, Zhang X, Hsu SH, He S, Wani NA, Barajas JM, Snyder LA, Frankel WL, Caligiuri MA et al: Blocking the CCL2-CCR2 Axis Using CCL2-Neutralizing Antibody Is an Effective Therapy for Hepatocellular Cancer in a Mouse Model. Molecular cancer therapeutics 2017, 16(2):312-322.
11. Lin A, Wang G, Zhao H, Zhang Y, Han Q, Zhang C, Tian Z, Zhang J: TLR4 signaling promotes a COX-2/PGE2/STAT3 positive feedback loop in hepatocellular carcinoma (HCC) cells. Oncoimmunology 2016, 5(2):e1074376.
12. Carvalho MI, Pires I, Prada J, Raposo TP, Gregório H, Lobo L, Queiroga FL: High COX-2 expression is associated with increased angiogenesis, proliferation and tumoural inflammatory infiltrate in canine malignant mammary tumours: a multivariate survival study. Veterinary & Comparative Oncology 2017, 15(2):619.
13. Lu Y, Shi C, Qiu S, Fan Z: Identification and validation of COX-2 as a co-target for overcoming cetuximab resistance in colorectal cancer cells. Oncotarget 2016, 7(40):64766-64777.
14. Wang D, DuBois RN: The role of COX-2 in intestinal inflammation and colorectal cancer. Oncogene 2009, 29(6):781-788.
15. Wewering F, Jouy F, Wissenbach DK, Gebauer S, Bluher M, Gebhardt R, Pirow R, von Bergen M, Kalkhof S, Luch A et al: Characterization of chemical-induced sterile inflammation in vitro: application of the model compound ketoconazole in a human hepatic co-culture system. Archives of toxicology 2017, 91(2):799-810.
16. Yang J, Lv X, Chen J, Xie C, Xia W, Jiang C, Zeng T, Ye Y, Ke L, Yu Y: CCL2-CCR2 axis promotes metastasis of nasopharyngeal carcinoma by activating ERK1/2-MMP2/9 pathway. Oncotarget 2016, 7(13):15632-15647.
17. Kong D, Gong L, Arnold E, Shanmugam S, Fort PE, Gardner TW, Abcouwer SF: Insulin-like growth factor 1 rescues R28 retinal neurons from apoptotic death through ERK-mediated BimEL phosphorylation independent of Akt. Experimental eye research 2016, 151:82-95.
18. Yu J, Ding WB, Wang MC, Guo XG, Xu J, Xu QG, Yang Y, Sun SH, Liu JF, Qin LX et al: Plasma circular RNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma: A large-scale, multicenter study. Int J Cancer 2020, 146(6):1754-1763.
19. Filliol A, Schwabe RF: FoxM1 Induces CCl2 Secretion From Hepatocytes Triggering Hepatic Inflammation, Injury, Fibrosis, and Liver Cancer. Cellular and molecular gastroenterology and hepatology 2020.
20. Qian BZ, Li J, Zhang H, Kitamura T, Zhang J, Campion LR, Kaiser EA, Snyder LA, Pollard JW: CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature 2011, 475(7355):222-225.
21. Che D, Zhang S, Jing Z, Shang L, Jin S, Liu F, Shen J, Li Y, Hu J, Meng Q: Macrophages induce EMT to promote invasion of lung cancer cells through the IL-6-mediated COX-2/PGE2/β-catenin signalling pathway. Molecular Immunology 2017, 90:197-210.
22. Iñiguez MA, Rodríguez A, Volpert OV, Fresno M, Redondo JM: Cyclooxygenase-2: a therapeutic target in angiogenesis. Trends in Molecular Medicine 2003, 9(2):73-78.
23. Yang JB, Zhao ZB, Liu QZ, Hu TD, Long J, Yan K, Lian ZX: FoxO1 is a regulator of MHC-II expression and anti-tumor effect of tumor-associated macrophages. Oncogene 2018, 37(9):1192-1204.
24. Chen G, Yu D, Xue N, Liu J, Koenig RJ, Xu B, Sheng L: LncRNA SRA promotes hepatic steatosis through repressing the expression of adipose triglyceride lipase (ATGL). Scientific Reports 2016, 6:35531.
25. Asada S, Daitoku H, Matsuzaki H, Saito T, Sudo T, Mukai H, Iwashita S, Kako K, Kishi T, Kasuya Y et al: Mitogen-activated protein kinases, Erk and p38, phosphorylate and regulate Foxo1. Cell Signal 2007, 19(3):519-527.
26. Guo F, Xu D, Lin Y, Wang G, Wang F, Gao Q, Wei Q, Lei S: Chemokine CCL2 contributes to BBB disruption via the p38 MAPK signaling pathway following acute intracerebral hemorrhage. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2020, 34(1):1872-1884.
27. Zhao D, Liu H, Liu H, Zhang X, Zhang M, Kolluri VK, Feng X, He Z, Wang M, Zhu T et al: Downregulated expression of hsa_circ_0037515 and hsa_circ_0037516 as novel biomarkers for non-small cell lung cancer. Am J Transl Res 2020, 12(1):162-170.
28. Dehne N, Mora J, Namgaladze D, Weigert A, Brune B: Cancer cell and macrophage cross-talk in the tumor microenvironment. Curr Opin Pharmacol 2017, 35:12-19.
29. Kim J, Bae JS: Tumor-Associated Macrophages and Neutrophils in Tumor Microenvironment. Mediators of inflammation 2016, 2016:6058147.
30. Qian BZ, Pollard JW: Macrophage Diversity Enhances Tumor Progression and Metastasis. Cell 2010, 141(1):39-51.
31. Zou Y, Zheng S, Deng X, Yang A, Xie X, Tang H, Xie X: The Role of Circular RNA CDR1as/ciRS-7 in Regulating Tumor Microenvironment: A Pan-Cancer Analysis. Biomolecules 2019, 9(9).
32. Nairismagi ML, Vislovukh A, Meng Q, Kratassiouk G, Beldiman C, Petretich M, Groisman R, Fuchtbauer EM, Harel-Bellan A, Groisman I: Translational control of TWIST1 expression in MCF-10A cell lines recapitulating breast cancer progression. Oncogene 2012, 31(47):4960-4966.
33. Fridlender ZG, George B, Veena K, Guanjun C, Jing S, Sunil S, M Cecilia C, Cecilia C, Wang LCS, Daniel H: CCL2 blockade augments cancer immunotherapy. Cancer Research 2010, 70(1):109.
34. Li X, Yao W, Yuan Y, Chen P, Li B, Li J, Chu R, Song H, Xie D, Jiang X: Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma. Gut 2015, 66(1):157.
35. Loberg RD, Day LSL, Jason H, Chi Y, John LN, St, Ryan G, Neeley CK, Pienta KJ: CCL2 is a potent regulator of prostate cancer cell migration and proliferation. Neoplasia 2006, 8(7):578-586.
36. Roblek M, Strutzmann E, Zankl C, Adage T, Heikenwalder M, Atlic A, Weis R, Kungl A, Borsig L: Targeting of CCL2-CCR2-Glycosaminoglycan Axis Using a CCL2 Decoy Protein Attenuates Metastasis through Inhibition of Tumor Cell Seeding 1. Neoplasia 2016, 18(1):49-59.
37. Gungor H, Ilhan N, Eroksuz H: The effectiveness of cyclooxygenase-2 inhibitors and evaluation of angiogenesis in the model of experimental colorectal cancer. Biomedicine & Pharmacotherapy 2018, 102:221-229.
38. Tikhanovich I, Cox J, Weinman SA: Forkhead box class O transcription factors in liver function and disease. J Gastroenterol Hepatol 2013, 28 Suppl 1:125-131.
39. Hsu CK, Lin CC, Hsiao LD, Yang CM: Mevastatin ameliorates sphingosine 1-phosphate-induced COX-2/PGE2-dependent cell migration via FoxO1 and CREB phosphorylation and translocation. British Journal of Pharmacology 2016, 172(22):5360-5376.